| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Robert Charles Peterson is Chief Financial Officer at BTMD. Robert Charles Peterson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Robert Charles Peterson has 6 Form 4 filings on record from February 2024 to June 2026, all as Interim CEO at biote (BTMD), 2024–2026.
The 8 reported transactions were 5 option or other derivative awards, 2 open-market sales and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $290K.
The largest open-market sale was 32,874 shares of BTMD at an average $6.20 on September 9, 2024, about $204K. Twelve months later BTMD was down 46%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.